These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9712175)

  • 1. Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans.
    Kreiss C; Schwizer W; Borovicka J; Jansen JB; Bouloux C; Pignol R; Bischof Delaloye A; Fried M
    Regul Pept; 1998 Jun; 74(2-3):143-9. PubMed ID: 9712175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans.
    Borovicka J; Kreiss C; Asal K; Remy B; Mettraux C; Wells A; Read NW; Jansen JB; D'Amato M; Delaloye AB; Fried M; Schwizer W
    Am J Physiol; 1996 Sep; 271(3 Pt 1):G448-53. PubMed ID: 8843769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans.
    Hidalgo L; Clavé P; Estorch M; Rodríguez-Espinosa J; Rovati L; Greeley GH; Capellà G; Lluís F
    Neurogastroenterol Motil; 2002 Oct; 14(5):519-25. PubMed ID: 12358680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
    Fried M; Schwizer W; Beglinger C; Keller U; Jansen JB; Lamers CB
    Diabetologia; 1991 Oct; 34(10):721-6. PubMed ID: 1959704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
    Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
    J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific adaptation of gastric emptying to diets with differing protein content in the rat: is endogenous cholecystokinin implicated?
    Shi G; Leray V; Scarpignato C; Bentouimou N; Bruley des Varannes S; Cherbut C; Galmiche JP
    Gut; 1997 Nov; 41(5):612-8. PubMed ID: 9414966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
    Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
    Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin does not delay gastric emptying of regular meals in healthy humans.
    Niederau C; Mecklenbeck W; Heindges T
    Hepatogastroenterology; 1993 Aug; 40(4):380-3. PubMed ID: 8406310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
    Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin in the gastric motor response to a meal in horses.
    Lorenzo-Figueras M; Merritt AM
    Am J Vet Res; 2006 Dec; 67(12):1998-2005. PubMed ID: 17144800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
    Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in man.
    Froehlich F; Gonvers JJ; Fried M
    Dig Dis Sci; 1995 Mar; 40(3):529-33. PubMed ID: 7895538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
    Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.